Skip to main content
Log in

The predictive value of serum progesterone and 17-OH progesterone levels onin vitro fertilization outcome

  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

In order to identify parameters which predict prognosis for success with in vitro fertilization, 17-hydroxyprogesterone and progesterone levels were evaluated in 254 patients undergoing 296 in vitro fertilization cycles. Selected response and outcome data were recorded.

Results

Patients with intermediate values of serum progesterone (0.7–0.8 ng/ml) at the time of human chorionic gonadotropin administration achieved significantly higher pregnancy rates than patients with lower (<0.7 ng/ml) or higher (>0.8 ng/ml) levels. The clinical pregnancy rates were 46%, 31%, and 27% respectively (P = 0.02). There was no change in 17-hydroxyprogesterone concentration which predicted a higher pregnancy rate.

Conclusion

Excellent clinical pregnancy rates were noted in cycles with a progesterone level of 0.7–0.8 ng/ml, as well as good results in cycles above 0.8 ng/ml. There is therefore no reason to administer human chorionic gonadotropin at a smaller follicle size to prevent a rise in serum progesterone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Meldrum DR, Wisot A, Hamilton F, Gutlay AL, Kempton W, Huynh: Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval. Fertil Steril 1989;51:455

    PubMed  Google Scholar 

  2. Lejeune B, Degueldre M, Camus M, Vekemans M, Opsomer L, Leroy F: In vitro fertilization and embryo transfer as related to endogenous luteinizing hormone rise or human chorionic gonadotropin administration. Fertil Steril 1986;45: 377–383

    PubMed  Google Scholar 

  3. Stanger JD, Yovich JL: Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. Br J Obstet Gynaecol 1985;92:85–93

    Google Scholar 

  4. Kagawa T, Shuji Y, Souya N, Shinji M, Toshihiro A: Relationship among serum levels of luteinizing hormone, estradiol, and progesterone during follicle stimulation and results of in vitro fertilization and embryo transfer (IVF-ET). J Asst Reprod Genet 1992;9:106–112

    Google Scholar 

  5. Dirnfield M, Goldman S, Gonen Y, Koifman M, Lissak A, Abramovici H: A modest increase in serum progesterone levels on the day of human chorionic gonadotropin (hCG) administration may influence pregnancy rate and pregnancy loss in vitro fertilization-embryo transfer (IVF-ET) patients. J Asst Reprod Genet 1993;10:126–129

    Google Scholar 

  6. Schoolcraft W, Sinton E, Schlenker T, Huynh D, Hamilton F, Meldrum DR: Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. Fertil Steril 1991;55:563–566

    PubMed  Google Scholar 

  7. Silverberg K, Burns W, Olive D, Reihl R, Schenken R: Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins. J Clin Endocrinol Metab 1990;73:797–803

    Google Scholar 

  8. Edelstein MC, Steltman HJ, Cox BJ, Robinson SM, Shaw RA, Muasher SJ: Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome. Fertil Steril 1990;54:853–857

    PubMed  Google Scholar 

  9. Givens CR, Shriock ED, Dandekar PV, Martin MC: Elevated serum gonadotropin levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles. Fertil Steril 1994;62:1011–1017

    PubMed  Google Scholar 

  10. Daly D, Hager M, VanderVeen H, Sokolowski SB: Using the increase in 17-OH progesterone as the hCG trigger during hMG therapy. Abstract #O-130, The American Fertility Society Annual Meeting, 1993

  11. deZiegler D, Cedars MI, Randle D, Lu JKH, Judd HL, Meldrum DR: Suppression of the ovary using a gonadotropin-releasing hormone agonist prior to stimulation for oocyte retrieval. Fertil Steril 1987;48:807

    PubMed  Google Scholar 

  12. Palermo R, Amodeo G, Navot D, Rosenwaks Z, Cittadini E: Concomitant gonadotropin-releasing hormone agonist and menotropin treatment for the synchronized induction of multiple follicles. Fertil Steril 1988;49:290

    PubMed  Google Scholar 

  13. Levy MJ, Engel D, Nelson KM, Feldman P, Sagoskin A: Microinsemination of oocytes as an effective treatment of severe male factor infertility. Abstract #P-008, The American Fertility Society Annual Meeting, 1993

  14. Silverberg KM, Martin M, Olive DL, Burns W, Schenken RS: Elevated serum progesterone levels on the day of human chorionic gonadotropin administration in in vitro fertilization cycles do not adversely affect embryo quality. Fertil Steril 1994;61:508–513

    PubMed  Google Scholar 

  15. Mio Y, Sekijima A, Iwabe T, Onohara Y, Harada T, Terakawa N: Suble rise in serum progesterone during the follicular phase as a predictor of the outcome of in vitro fertilization. Fertil Steril 1992;58:159–166

    PubMed  Google Scholar 

  16. Feldberg D, Goldman G, Ashkenazi J, Dicker D, Shelef M, Goldman J. The impact of high progesterone levels in the follicular phase of in vitro fertilization (IVF) cycles: a comparative study. J In Vitro Fert Embryo Transf 1989;6:11–14

    PubMed  Google Scholar 

  17. Fanchin R, deZiegler D, Taieb J, Hazout A, Frydman R: Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer. Fertil Steril 1993;59:1090–1094

    PubMed  Google Scholar 

  18. Trounson AO, Calabrese R: Changes in plasma progesterone concentrations around the time of the luteinizing hormone surge in women super-ovulated for in vitro fertilization. J Clin Endocrinol Metab 1984;59:1075–1080

    PubMed  Google Scholar 

  19. Moor RM, Polge C, Willadsen SM: Effects of follicular steroids on the maturation and fertilization of mammalian oocytes. J Embryol Exp Morphol 1980,56:319–335

    PubMed  Google Scholar 

  20. Hofmann GE, Bentzien F, Bergh PA, Garrisi GJ, Williams MC, Guzman I,et al: Premature luteinization in controlled ovarian hyperstimulation has no adverse affect on oocyte and embryo quality. Fertil Steril 1993;60:675–679

    PubMed  Google Scholar 

  21. Paulson RJ, Saur MV, Francis MM,et al: In vitro fertilization in unstimulated cycles: a clinical trial using hCG for timing of follicle aspiration. Obstet Gynecol 1990;76:788

    PubMed  Google Scholar 

  22. Foulot H, Ranoux C, Dubisson JB,et al: In vitro fertilization without ovarian stimulation: a simplified protocol applied in 80 cycles. Fertil Steril 1989;52:617

    PubMed  Google Scholar 

  23. Levy M, Gindoff P, Hall J,et al: The efficacy of natural versus stimulated cycle IVF-ET. Abstract #0-035, The American Fertility Society Annual Meeting, 1991

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Levy, M.J., Smotrich, D.B., Widra, E.A. et al. The predictive value of serum progesterone and 17-OH progesterone levels onin vitro fertilization outcome. J Assist Reprod Genet 12, 161–166 (1995). https://doi.org/10.1007/BF02211792

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02211792

Key words

Navigation